Publication PMID: 40168094

Tsou PS, Ali RA, Lu C, Sule G, Carmona-Rivera C, Lucotti S, Ikari Y, Wu Q, Campbell P, Gurrea-Rubio M, Maeda K, Fox SE, Brodie WD, Mattichak MN, Foster C, Tambralli A, Yalavarthi S, Amin MA, Kmetova K, Mazetto Fonseca B, Chong E, Zuo Y, Maile M, Imberti L, Caruso A, Caccuri F, Quaresima V, Sottini A, Kuhns DB, Fink DL, Castagnoli R, Delmonte O, Kenney H, Zhang Y, Magliocco M, Su HC, Notarangelo LD, Zemans RL, Mao-Draayer Y, Matei I, Salvatore M, Lyden DC, Kanthi Y, Kaplan MJ, Knight JS, Fox DA. Soluble CD13 is a potential mediator of neutrophil-induced thrombogenic inflammation in SARS-CoV-2 infection. JCI Insight, 2025 April, PMID: 40168094, PMCID: PMC12128962